Clinical Trial Update: Evaluation of Insulin Glulisine (GP40321) Compared to Insulin Glulisine (Apidra® SoloStar®) in Type 1 Diabetes Mellitus Patients [Phase 3]

View source ↗

Summary

Phase 3 trial completed comparing GP40321 with Apidra SoloStar insulin glulisine in adults with type 1 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Apidra SoloStar (insulin glulisine)
• GP40321 (insulin glulisine GP40321)

Snippet

Sponsor: Geropharm | Conditions: Type 1 Diabetes Mellitis | Phase 3 | Status: COMPLETED